Methylene Blue (MB) is a bioactive substance as well as a blue dye. It has been used for more than a century in the dyeing of cotton, and then for treating malaria and methemoglobinemia. Today, it is being explored for its use in improving brain health, increasing energy and focus, treating resistant infections like Lyme disease, and decreasing dementia and Alzheimer’s risks. 

 

Methylene Blue is a cognitive and mitochondrial enhancer, improving memory and mood, and increasing brain cell respiration (how it uses oxygen). It assists the mitochondria, the powerhouse in our cells, to increase ATP production (energy), and increase the natural production of NAD. MB has been used to slow the progression of parkinson’s, multiple sclerosis, spinal cord injuries, and stroke by protecting neurons and prolonging the life of these important cells. 

 

Another promising benefit is its ability to inactivate or kill pathogens such as parasites, fungi, bacteria and viruses, including COVID. It is used in treating Lyme disease, candida, mycotoxin and mold infections, and resistant bacterial strains. 

The antioxidant and anti-inflammatory properties of Methylene Blue enhance the health benefits to help prevent diseases like heart disease and cancers. MB has also been found to protect against radiation-induced tissue injury by reducing oxidative stress and inflammation in cancer patients undergoing radiation.